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In a logistic regression analysis, the only significant associations with blood
transfusion in open prostatectomy were the duration of surgery (.042), co-
morbidity (.006) and the pre-operative haemoglobin level (.000).
Conclusion: The intra-operative blood transfusion rate in open prostatec-
tomy for BPH in this series was 21.5%. Blood transfusion rate was associated
with and significantly higher in emergency surgeries, in the absence of
co-morbidities and with procedures done under general anaesthesia. Using
logistic regression analysis, the main determinants of transfusion were the
duration of surgery, comorbidity and the pre-operative haemoglobin level.
http://dx.doi.org/10.1016/j.afju.2014.03.009
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Introduction: Testicular atrophy in patients with prostate cancer (CaP) has
been associated with poor outcome. We have previously reported that 65%
of our newly diagnosed CaP patients treated with bilateral orchidectomy
had testicular atrophy. This is a pilot retrospective study evaluating the rela-
tionship between histologic grade and severity of testicular atrophy in these
patients.
Methods: Data was collated from records of patients who had therapeu-
tic bilateral orchidectomy for prostate cancer between 2002 and 2012. The
Histology was reported by a Consultant Pathologist. Testicular atrophy was
graded as none (normal), mild, moderate or severe based on the degree of
testicular tubular sclerosis found at histology. CaP specimens were graded
using the Gleason scoring systems. Analysis was done using SPSS version
18.
Results: The histology of 164 prostate biopsies and 113 orchidectomy speci-
mens from prostate cancer patients were analyzed. The age range was 36-91
years; mean age was 69.23 years (SD 9.446 years). The Gleason’s score
ranged 4–10, mean 6.95 (SD 1.44). 64 patients (39%) had GS of 4–6, 87
(53%) had GS of 7–8 and 13 (8%) had GS 9–10. 21 (18.6%) had normal
testis, 39 (34.5%) had mild, 16 (14.2%) had moderate and 37 (32.7%) had
severe testicular atrophy. There was no statistically significant difference in
GS among the four groups; F = 1.555; Sig. 0.221.
Conclusion: Most patients in our environment with advanced prostate cancer
have testicular atrophy, the degree of which is unrelated to histology grade
of the tumour.
http://dx.doi.org/10.1016/j.afju.2014.03.010
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Objectives: To study clinical incidence of histologically proven PC, TNM
stage and management outcomes
Methods: Case expansion study of PC managed in Accra, abstracted records
2004–2012.
Diagnosis by history, Hogh PSA, physical and abnormal DRE and his-
tologically confirmed by biopsy. With gleason scores (GS) and TNM
staged and managed by approved protocols. Organ confined PC by radical
prostatectomy (RP), brachytherapy (BRCHY), external beam radiotherapy
(EBRT), Hormonal/Chemotherapy, or surveillance if life expectancy less
than 15 years. T3-4M0 treated by hormonal/chemotherapy ± Total androgen
blockade (TAB), BRCHY/EBRT. Metastatic T1-4-M1 is treated by hor-
monal/chemotherapy ± TAB. Significant LUTO is treated by alpha blockers,
TUIP/TURP.
Results: There were 669 cases median age 70 years, median GS 7,organ
confined PC 415 (62%), T3-4 M0 167 (25%), METASTATIC CASES 87
(13%). The report on 669 cases were followed for 1–7 years is as follows.
A. Organ Confined T1-2 N0 M0 PC – n = 415 presentation is asymptomatic.
Symptomatic cases 1–20% treatment regimes
i) Radical Prostatectomy – n = 92. Open retropubic/prior median PSA
16.1 ng/ml, post PSA 0.23 ng/ml. RP specimen BPH = 3, organ con-
fined 76, positive margins 13. Complications rate (COMP) 3–22%.
ii) Brachytherapy – n = 70.145 GY, median prior PSA 14.6 ng/ml, post
PSA 0.59 ng/ml. COMP 3–10%.
iii) EBRT no = 155. 70/74GY. Median prior PSA 15.7 ng/ml post PSA
0.54 ng/ml. COMP 2–6%.
iv) Hormonal Chemotherapy + TAB – n = 98 prior median PSA
48.5 ng/ml, post PSA 0.6 ng/ml. METHODS LHRH analogue
/Chemotherapy 41%, stilboesterol 29%, BTO 30%. COMP 4–30%.
v) Surveillance GS 6.prior PSA < 8 ng/ml. Presentation symptomatic
60%.
All had neoadjuvant hormonal/chemotherapy + TAB, LHRH 52%,
stilboesterol 12%, BTO36% then
i) Bachytherapy – T3N3, prior PSA 14.6 ng/ml, post PSA 0.11 ng/ml.
ii) EBRT. no-64. Prior PSA T3 (34%) 32.4 ng/ml, T4 (2%) 64.6 ng/ml,
Post PSA T3 0.6 ng/ml, T4 0.4 ng/ml, COMP = 2–70%.
iii) Hormonal chemotherapyn = 103 (T3 24%, T4 38%), LHRH 28%
stilboesterol 4%, BTO 30%, COMP 4–35%, Hospitalmortality
26.3%.
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B. Advanced Metastatic T1-4 N1-3 M1 n = 87, 13% median prior PSA
93 ng/ml, post PSA 0.4 ng/ml. Presentation all symptomatic .RX LHRH
23%, Stilboesterol 17%, BTO 60%, COMP 20–34%, Hospital mortality
37%.
Conclusions: Prior to 2000 15.3% organ confined, T3/T4 32% and
metastatic 52%. Improved facilities and skilled teams since 2004 led to organ
confined PC 62% curable by RP, brachytherapy or EBRT with longer disease
free survival but advanced disease pose challenges for disease control.
http://dx.doi.org/10.1016/j.afju.2014.03.011
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Introduction and objectives: Surgical excision remains the definitive treat-
ment of benign prostatic hypertrophy and in this regard, open enucleation
is the gold standard. Due to the morbidity associated with open surgery,
less invasive methods of prostatic excision have been developed of which
transurethral resection is the oldest and most widely used. However, mini-
mally invasive procedures are best suited for small glands (80 g) whilst the
glands of most black African men are large (100 g) making them unsuitable
for enucleation via these methods. Also, the equipment and/or expertise for
TURP are not widely available in sub-Saharan Africa. In our centre, open
prostatectomy is the preferred option in ninety percent of patients requiring
surgical treatment for BPH.
Methods: In this report, we describe our methods of open (retropubic) pros-
tatectomy and emphasize modifications to the technique that have reduced
morbidity and improved our results. We also compare the results of open
prostatectomy with TURP in a select group of patients.
Conclusion: Retropubic prostatectomy is safe for treatment of large/very
large prostate for which TURP would be difficult.
http://dx.doi.org/10.1016/j.afju.2014.03.012
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Objectives: To highlight the serious problem of urethral strictures devel-
oping as a result of catheterization either from traumatic catheterization or
allergic reaction to catheters or infection.
To make recommendations to reduce the incidence of catheter associated
urethral strictures.
Patients and methods: We reviewed our data base of patients coming
for urethroplasties over a one year period at the Komfo Anokye Teach-
ing Hospital from October 2012 to September 2013 to describe the stricture
characteristics of those caused by catheters.
Results: Overall, 100 urethroplasties for urethral strictures were done during
the study period. Of these, 15 were catheter associated. Most were located in
the anterior urethra, most were multiple and of long lengths. Tissue transfer
was employed in repair of most of these strictures.
Conclusions: Catheter associated urethral strictures are common, they are
more complex, they require long surgery hours and their repairs are associ-
ated with more complications hence the need to prevent their occurrence.
http://dx.doi.org/10.1016/j.afju.2014.03.013
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We present three cases of complex urethral strictures seen and managed at
KATH to highlight the challenges faced with urethral stricture disease and
the outcomes of management.
We discuss the case of a 46 year old man with pan urethral stricture fol-
lowing catheterization for Laminectomy, an 11 year old boy with a crush
pelvic injury with membranous urethral stricture who had to undergo three
urethroplasties before final relieve and finally the case of a 75 year old man
with a 6 cm bulbar urethral stricture which was catheter associated who also
had benign Prostatic hyperplasia and had to undergo urethroplasty as well
as simple prostatectomy before final relieve.
http://dx.doi.org/10.1016/j.afju.2014.03.014
